Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. (Q39219981)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. |
scientific article |
Statements
1 reference
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. (English)
1 reference
Robert J Wells
1 reference
Mary T Adams
1 reference
Todd A Alonzo
1 reference
Robert J Arceci
1 reference
Jonathan Buckley
1 reference
Allen B Buxton
1 reference
Kathryn Dusenbery
1 reference
Alan Gamis
1 reference
Margaret Masterson
1 reference
Terry Vik
1 reference
Phyllis Warkentin
1 reference
James A Whitlock
1 reference
Children's Cancer Group Study 2951
1 reference
1 August 2003
1 reference
1 reference
21
1 reference
15
1 reference
2940-2947
1 reference
Identifiers
1 reference
1 reference